Clinical Trial Update: Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction [NA]

View source ↗

Summary

A clinical trial evaluating Efferon CT hemoadsorption for cardiogenic shock in patients with acute myocardial infarction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Myocardial Infarction

Drugs mentioned

• Efferon CT Hemoadsorption

Snippet

Sponsor: Efferon JSC | Conditions: Myocardial Infarction, Cardiogenic Shock | NA | Status: RECRUITING